187 related articles for article (PubMed ID: 29520501)
1. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
[TBL] [Abstract][Full Text] [Related]
2. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
3. Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE; Lostumbo L; Wallace J; Ko H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
[TBL] [Abstract][Full Text] [Related]
4. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Heemskerk-Gerritsen BA; Rookus MA; Aalfs CM; Ausems MG; Collée JM; Jansen L; Kets CM; Keymeulen KB; Koppert LB; Meijers-Heijboer HE; Mooij TM; Tollenaar RA; Vasen HF; ; Hooning MJ; Seynaeve C
Int J Cancer; 2015 Feb; 136(3):668-77. PubMed ID: 24947112
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
6. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
7. Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
Mai PL; Lagos VI; Palomares MR; Weitzel JN
Ann Surg Oncol; 2008 Dec; 15(12):3415-21. PubMed ID: 18836779
[TBL] [Abstract][Full Text] [Related]
8. Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop
Casella D; Di Taranto G; Marcasciano M; Sordi S; Kothari A; Kovacs T; Lo Torto F; Cigna E; Ribuffo D; Calabrese C
Breast; 2018 Jun; 39():8-13. PubMed ID: 29455110
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
[TBL] [Abstract][Full Text] [Related]
10. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
[TBL] [Abstract][Full Text] [Related]
11. [Surgical prevention of breast carcinoma in patients with hereditary risk].
Dražan L; Veselý J; Hýža P; Kubek T; Foretová L; Coufal O
Klin Onkol; 2012; 25 Suppl():S78-83. PubMed ID: 22920212
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
13. Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
Evans DG; Ingham SL; Baildam A; Ross GL; Lalloo F; Buchan I; Howell A
Breast Cancer Res Treat; 2013 Jul; 140(1):135-42. PubMed ID: 23784379
[TBL] [Abstract][Full Text] [Related]
14. High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.
Yamauchi H; Okawa M; Yokoyama S; Nakagawa C; Yoshida R; Suzuki K; Nakamura S; Arai M
Breast Cancer Res Treat; 2018 Dec; 172(3):679-687. PubMed ID: 30203341
[TBL] [Abstract][Full Text] [Related]
15. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
[TBL] [Abstract][Full Text] [Related]
16. Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
Nagura N; Hayashi N; Takei J; Yoshida A; Ochi T; Iwahira Y; Yamauchi H
Breast Cancer; 2020 Jan; 27(1):70-76. PubMed ID: 31292927
[TBL] [Abstract][Full Text] [Related]
17. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
19. The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.
Basu NN; Hodson J; Chatterjee S; Gandhi A; Wisely J; Harvey J; Highton L; Murphy J; Barnes N; Johnson R; Barr L; Kirwan CC; Howell S; Baildam AD; Howell A; Evans DG
Sci Rep; 2021 Feb; 11(1):2847. PubMed ID: 33531640
[TBL] [Abstract][Full Text] [Related]
20. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Murphy BL; Yi M; Arun BK; Gutierrez Barrera AM; Bedrosian I
Ann Surg Oncol; 2020 Nov; 27(12):4613-4621. PubMed ID: 32720048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]